{"schema_version":"secwatch.filing_event.v1","accession":"0001402479-23-000023","form_type":"8-K/A","ticker":null,"cik":"0001402479","company_name":"MedAvail Holdings, Inc.","filed_at":"2023-04-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.713389+00:00","generated_at":"2026-06-17T05:03:44.428467+00:00","sec_items":["9.01","2.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"MedAvail substantially completes exit from pharmacy services; focuses on pharmacy tech business","bullets":["As of March 31, 2023, MedAvail substantially completed exit from pharmacy services; future focus solely on pharmacy tech.","Closed asset sale to CVS on Feb 10, 2023 for $2.9M final purchase price (up to $4.4M originally) with $0.1M fees and $0.2M holdback.","Pro forma shows elimination of pharmacy services revenue: $30.7M for 9mo Sep2022, $20.2M for FY2021.","Pro forma net loss reduced to $15.4M (9mo Sep2022) from historical $36.5M; discontinued ops treatment in Q1 2023 10-Q.","Company now solely a pharmacy technology business after exiting retail pharmacy operations."],"urls":{"canonical":"https://secwatch.observer/filing/0001402479-23-000023","json":"https://secwatch.observer/filing/0001402479-23-000023.json","markdown":"https://secwatch.observer/filing/0001402479-23-000023.md","text":"https://secwatch.observer/filing/0001402479-23-000023.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1402479/000140247923000023/0001402479-23-000023-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1402479/000140247923000023/medavail-20230118.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T05:03:44.428467+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"79776d3e65c8d6129c77a6acbebb8cd11c50b413","claim":"MedAvail Holdings, Inc. completed a disposition involving German Dobson CVS, L.L.C., Garfield Beach CVS, L.L.C., Longs Drug Stores California, L.L.C., Woodward Detroit CVS, L.L.C. and Holiday CVS, L.L.C. (collectively, \"CVS\") for final purchase price of $2.9 million (closed 2023-02-10).","evidence_excerpt":"On February 10, 2023, the Company closed the CVS Transaction for a final purchase price of $2.9 million; subject to $0.1 million fees and a $0.2 million holdback.","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1402479/000140247923000023/0001402479-23-000023-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"disposition"},{"label":"Counterparty","value":"German Dobson CVS, L.L.C., Garfield Beach CVS, L.L.C., Longs Drug Stores California, L.L.C., Woodward Detroit CVS, L.L.C. and Holiday CVS, L.L.C. (collectively, \"CVS\")"},{"label":"Consideration","value":"final purchase price of $2.9 million"},{"label":"Closing","value":"2023-02-10"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}